Search Videos and More
News
Leading-edge treatments for structural heart disease
WellSpan Health is a regional leader in the treatment of structural heart disease, offering enhanced techniques for transcatheter aortic valve replacement (TAVR) and for implanting the WATCHMAN device for left atrial appendage closure.
News
One-of-a-kind stroke prevention for patients with Afib
WellSpan is the first-in-the-US to anchor an in-lab 4D-CT imaging modality to ensure devices are positioned properly.
News
WellSpan cardiologists using sound waves to unblock arteries
WellSpan cardiologists now can open up severely calcified heart blockages with a new tool: sound waves.
News
TAVR keeps improving outcomes for aortic stenosis
Transcatheter aortic valve replacement (TAVR) has been an alternative to open surgery for decades. But many don’t know about its stunning results in reducing complications. Learn more from one of the nation’s leading TAVR experts.
News
Should we do genetic screening for CVD and other diseases?
Screening asymptomatic patients for CVD-causing genes can save lives, but many scientific and ethical questions must be answered before we know it’s worth it.
News
Pulsed field ablation: The new first-line AFib treatment
Ablation procedures can improve AFib if patients are treated early enough. Pulsed field ablation is a new technology that offers this benefit with less risk of serious complications. Learn how it’s transforming the AFib treatment landscape.
News
Catching abdominal aortic aneurysms before they burst
An abdominal aortic aneurysm (AAA) screening is recommended for men ages 65-75 who are or were smokers. Women with risk factors like a family history may also benefit. Find out who to screen for AAA, how to manage it and when to refer.
News
How pharmacogenomics is changing medication decisions
Genetic variants can affect how patients respond to medications. Learn how WellSpan Health is integrating pharmacogenomics into cardiovascular, oncology and psychotropic care to support safer, more personalized prescribing.
News
Excellence in chronic total occlusion treatment
Percutaneous coronary intervention (PCI) can help many patients with CTO who are experiencing severe shortness of breath and chest discomfort.